Medplus Health Services Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,037 Cr +21.3% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
MH

Medplus Health Services Ltd

Q4 FY26

Medplus Health Services Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,864Cr
+23.4% YoY
+3.2% QoQ
Net profit
₹64Cr
+25.5% YoY
+10.3% QoQ
Margin
9%
0 pp YoY
0 pp QoQ
Price₹690
Market cap₹8.3K Cr
P/E39.4

The short version

MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone. The company expects to maintain or improve gross margins, driven by increasing private label share.

From Medplus Health Services Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone.
  • The company expects to add approximately 800 new stores in FY27, including both company-owned and franchisee stores, indicating continued network expansion.
  • Same-store sales growth (SSSG) target remains at an annualized rate of 9% to 10% over the next year.
  • Private label growth guidance remains intact, aiming for a 20-30 basis points increase every quarter in private label share.

2 more points from Medplus Health Services Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation. (Page 16)
  • Expansion through franchisee model is ongoing, with approximately 310 franchisee stores added recently, supporting faster network growth alongside company-owned store expansion. (Page 5)
  • The company expects to continue store additions (around 800 stores next year), split between owned and franchisee stores, with more detailed splits to be shared in the future. (Page 5)

2 more points from Medplus Health Services Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Medplus Health Services Ltd Q4 FY26 results — key figures

Medplus Health Services Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue1,8641,510+23.4%1,806+3.2%
Operating profit (EBITDA)169136+24.3%159+6.3%
Operating margin9%9%0 pp9%0 pp
Profit before tax8061+31.1%73+9.6%
Net profit (PAT)6451+25.5%58+10.3%
EPS (₹)5.334.29+24.2%4.82+10.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Retailing this season

  • Intrasoft Technologies (Q4 FY26)

    Revenue from operations for the quarter ended Mar-26: ₹13,604.74 lakhs . Key investor presentation takeaways from Intrasoft Technologies's Q4 FY26 investor pres

  • Brand Concepts (Q4 FY26)

    Q4 FY26 Revenue from Operations: INR 90.42 Cr., up 25.0% YoY (Page 11) . Key investor presentation takeaways from Brand Concepts Ltd's Q4 FY26 investor presenta

  • Womancart (Q4 FY26)

    Revenue for H2FY26: ₹8,388.9 Lakhs, up 125.8% YoY (Page 10, 8) . Key investor presentation takeaways from Womancart's Q4 FY26 investor presentation — and how it

  • Avenue Supermarts (Q4 FY26)

    FY22: ₹30,353 Cr . Key investor presentation takeaways from Avenue Supermarts's Q4 FY26 investor presentation — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medplus Health Services Ltd Q4 FY26 results?

MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone. The company expects to maintain or improve gross margins, driven by increasing private label share.

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.